loader from loading.io

Promising New Cancer Screening Methods

PodcastDX

Release Date: 02/10/2026

Promising New Cancer Screening Methods show art Promising New Cancer Screening Methods

PodcastDX

Promising new cancer screening methods are pivoting toward  (MCED) blood tests (liquid biopsies) and AI-enhanced imaging, which aim to detect multiple cancer types from a single, non-invasive sample, often before symptoms arise. These technologies, including the  and , analyze DNA, proteins, or methylation patterns to identify cancer signals.  Multi-Cancer Early Detection (MCED) Blood Tests: These tests, often called liquid biopsies, detect DNA or proteins shed by cancer cells into the bloodstream, identifying early-stage cancers (e.g., ovarian, pancreatic)...

info_outline
Chronic Illness Isn't Rare Anymore: Why The System Is Trying To Catch-up show art Chronic Illness Isn't Rare Anymore: Why The System Is Trying To Catch-up

PodcastDX

Chronic illness is now the norm, not the exception, and our healthcare system is scrambling to keep up. ​In this episode, “Chronic Illness Isn't Rare Anymore: Why The System Is Trying To Catch Up,” we dig into why so many adults are living with at least one chronic condition, how the current system was built for short-term, acute care, and what that mismatch means for people trying to manage complex, lifelong diagnoses. We talk about the hidden costs of navigating appointments, medications, insurance, and burnout, and explore what needs to change—from prevention and policy to care...

info_outline
From Survival to Quality of Life: show art From Survival to Quality of Life:

PodcastDX

FROM SURVIVAL TO QUALITY OF LIFE: WHY OUTCOMES ARE BEING REDEFINED THE FUNDAMENTAL SHIFT IN MEDICINE For decades, medicine measured success through a singular lens: survival. Did the patient live? Did the procedure work? While these metrics remain important, healthcare is undergoing a profound transformation that redefines what "winning" actually means[1]. The new standard is no longer just extending life—it's enabling patients to live purposefully, functionally, and with dignity[2]. This shift reflects a critical insight: surviving is not the same as living well. WHY OUTCOMES ARE BEING...

info_outline
Ai in Medicine Tool Partner or Problem show art Ai in Medicine Tool Partner or Problem

PodcastDX

AI in medicine is best understood as a powerful tool and a conditional partner that can enhance care when tightly supervised by clinicians, but it becomes a problem when used as a replacement, deployed without oversight, or embedded in biased and opaque systems. Whether it functions more as a partner or a problem depends on how health systems design, regulate, and integrate it into real clinical workflows.​ Where AI Works Well Decision support and diagnosis: AI can read imaging, ECGs, and lab patterns with very high accuracy, helping detect cancers, heart...

info_outline
Medicine in Transition:   show art Medicine in Transition:

PodcastDX

Medicine has transitioned due to massive tech adoption (Electronic Health Records EHRs, Artificial Intelligence AI, Telehealth), shifting patient expectations (consumerism, convenience), the rise of value-based care, new treatments (precision medicine), and increased focus on population health and prevention, all while grappling with rising costs, data security, and persistent access/equity gaps, making healthcare more data-driven, personalized, and digitally integrated but also more complex and fragmented.  We try to break it down to try and understand the changes and how they might...

info_outline
A Primer on Stem Cells show art A Primer on Stem Cells

PodcastDX

​ This week we discuss stem cells.  Having great therapeutic and biotechnological potential, stem cells are extending the frontier in medicine. Not only replace dysfunctional or damaged cells, the so-called regenerative medicine, stem cells may also offer us new perspectives regarding the nature of aging and cancer. This review will cover some basics of stem cells, their current development, and possible applications in medicine. Meanwhile, important remaining challenges of stem cell research are discussed as well. ​Stem cells are unique, unspecialized cells that can divide to create...

info_outline
Functional Fitness show art Functional Fitness

PodcastDX

This week we will discuss the topic of "functional fitness"  With the new year upon us many people want to add fitness or getting healthy as goals and we are here to help! Functional fitness is a simple, effective way to keep your body moving and reduce restlessness. It focuses on exercises that help you perform everyday activities more easily and safely—like getting up off the floor, carrying groceries, or reaching for items on a shelf. By training your muscles to work the way you actually use them in daily life, functional fitness reduces injury risk and improves overall quality of...

info_outline
Why New Year Resolutions Often Fail show art Why New Year Resolutions Often Fail

PodcastDX

By the end of the first week of the new year, nearly 77% of New Year’s resolutions have already failed (Norcross, 1988). That’s discouraging—but it doesn’t mean you should stop trying. It means most of us are setting resolutions in ways that don’t work. You aren’t weak or lazy. More often, the problem is a misaligned system—one that relies too heavily on willpower and short-lived motivation. Motivation naturally fades over time, even when our intentions are good. Think about how often you enthusiastically agree to plans weeks in advance, only to feel tired or unmotivated when...

info_outline
The Lymphatic System show art The Lymphatic System

PodcastDX

The lymphatic system, or lymphoid system, is one of the components of the circulatory system, and it serves a critical role in both immune function and surplus extracellular fluid drainage.  Components of the lymphatic system include lymph, lymphatic vessels and plexuses, lymph nodes, lymphatic cells, and a variety of lymphoid organs. The pattern and form of lymphatic channels are more variable and complex but generally parallel those of the peripheral vascular system. The lymphatic system partly functions to convey lymphatic fluid, or lymph, through a network of lymphatic channels,...

info_outline
Pancreatic Cancer show art Pancreatic Cancer

PodcastDX

This week we are talking about Pancreatic cancer.  This is a type of cancer that begins as a growth of cells in the pancreas. The pancreas lies behind the lower part of the stomach. It makes enzymes that help digest food and hormones that help manage blood sugar. The most common type of pancreatic cancer is pancreatic ductal adenocarcinoma. This type begins in the cells that line the ducts that carry digestive enzymes out of the pancreas. Pancreatic cancer rarely is found at its early stages when the chance of curing it is greatest. This is because it often doesn't cause symptoms until...

info_outline
 
More Episodes
Promising new cancer screening methods are pivoting toward multi-cancer early detection (MCED) blood tests (liquid biopsies) and AI-enhanced imaging, which aim to detect multiple cancer types from a single, non-invasive sample, often before symptoms arise. These technologies, including the Galleri test and Novelna's protein-based tests, analyze DNA, proteins, or methylation patterns to identify cancer signals.
  • Multi-Cancer Early Detection (MCED) Blood Tests: These tests, often called liquid biopsies, detect DNA or proteins shed by cancer cells into the bloodstream, identifying early-stage cancers (e.g., ovarian, pancreatic) that lack standard screening protocols.
    • Galleri Test: Analyzes chemical methylation patterns to detect over 50 types of cancer, with the potential to indicate the cancer's origin in the body.
    • Novelna's Test: An experimental test analyzing protein signatures, showing high accuracy in identifying 18 early-stage cancers, including 93% of stage 1 cancers in men.
    • TriOx Test: A new, Oxford-developed test showing high sensitivity in detecting trace cancer DNA.
  • AI and Machine Learning in Screening: AI is enhancing existing imaging techniques (e.g., mammography) to improve accuracy and efficiency in reading scans, reducing false positives.
  • Other Liquid Biopsies: Research into analyzing blood, breath, and urine for early signs of cancer, offering a less invasive alternative to tissue biopsies.
While offering immense promise for reducing cancer mortality, many of these technologies, including MCED, are still in research or early implementation phases, and they can produce false positives.